Pam Murphy | IR Consultant |
William Collier | President, CEO |
David Hastings | CFO & CAO |
Gaston Picchio | Chief Development Officer |
Michael Sofia | Chief Scientific Officer |
Keay Nakae | Chardan |
Jeffrey Tan | B. Riley FBR |
Good day, ladies and gentlemen, and welcome to the Arbutus Biopharma Corporation 2019 Second Quarter Financial Results and Corporate Update Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded.
I would not like to introduce your host for today's conference Pam Murphy.